Get startedLog in
    Picture of Clarity Pharmaceuticals logo

    CU6 — Clarity Pharmaceuticals News Story

    0.000.00%
    au flag iconLast trade - 00:00
    HealthcareSpeculativeMid CapSucker Stock
    All News

    Brief: First Patient Treated In Clarity's Therapeutic Prostate Cancer Trial

    Picture of Clarity Pharmaceuticals logoClarity Pharmaceuticals
    07/10/2022 14:25
    Oct 7 (Reuters) - Clarity Pharmaceuticals Ltd  CU6.AX :
    * FIRST PATIENT TREATED IN CLARITY'S THERAPEUTIC PROSTATE
CANCER
TRIAL

Source text for Eikon:  ID:nPn2KMkM8a 
Further company coverage:  CU6.AX 
 ((Reuters.Briefs@thomsonreuters.com;;))

    Recent news on Clarity Pharmaceuticals

    See all news